Avantor (AVTR) Other Non-Current Liabilities (2018 - 2026)
Avantor's (AVTR) quarterly Other Non-Current Liabilities came in at $377.3 million in Q1 2026, up 3.48% year-on-year from $364.6 million in Q1 2025, and little changed quarter-over-quarter from $378.2 million in Q4 2025.
Avantor (AVTR) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $377.3 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 3.48% year-over-year to $377.3 million in Q1 2026; TTM through Mar 2026 was $377.3 million, a 3.48% increase from a year earlier, with the FY2025 full-year figure at $378.2 million, up 5.55% from the prior year.
- Other Non-Current Liabilities was little changed at $377.3 million in Q1 2026 per AVTR's latest filing, from $378.2 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $418.9 million in Q3 2024 and bottomed at $268.8 million in Q2 2023.
- The 5-year median for Other Non-Current Liabilities is $360.7 million (2024), against an average of $349.8 million.
- Across the five-year window, Other Non-Current Liabilities slipped 23.55% in 2023 and surged 54.4% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $295.4 million in 2022, then climbed by 18.58% to $350.3 million in 2023, then gained by 2.28% to $358.3 million in 2024, then increased by 5.55% to $378.2 million in 2025, then retreated by 0.24% to $377.3 million in 2026.
- Per Business Quant, the three latest AVTR Other Non-Current Liabilities figures stand at $377.3 million (Q1 2026), $378.2 million (Q4 2025), and $402.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 377.30 Mn |
| Dec 31, 2025 | 378.20 Mn |
| Sep 30, 2025 | 402.60 Mn |
| Jun 30, 2025 | 391.40 Mn |
| Mar 31, 2025 | 364.60 Mn |
| Dec 31, 2024 | 358.30 Mn |
| Sep 30, 2024 | 418.90 Mn |
| Jun 30, 2024 | 361.90 Mn |
| Mar 31, 2024 | 360.70 Mn |
| Dec 31, 2023 | 350.30 Mn |
| Sep 30, 2023 | 271.30 Mn |
| Jun 30, 2023 | 268.80 Mn |
| Mar 31, 2023 | 300.10 Mn |
| Dec 31, 2022 | 295.40 Mn |
| Sep 30, 2022 | 334.10 Mn |
| Jun 30, 2022 | 351.60 Mn |
| Mar 31, 2022 | 361.10 Mn |
| Dec 31, 2021 | 358.40 Mn |
| Sep 30, 2021 | 403.00 Mn |
| Jun 30, 2021 | 411.60 Mn |